Core Viewpoint - He Eye Hospital (301103) expects a net profit attributable to shareholders of 24 million to 36 million for 2025, representing a year-on-year growth of 187.60% to 231.40% [1] Group 1: Performance Improvement - The company has achieved a turnaround from loss to profit during the reporting period, driven by business structure optimization, effective cost control, and the disposal of inefficient assets [1] - Significant enhancement in profitability is attributed to the continuous optimization of the business structure, with a focus on high-margin refractive and optical businesses [1] Group 2: Cost and Efficiency Management - The company has implemented refined operational management, achieving cost reduction and efficiency improvement through centralized procurement optimization, supply chain efficiency enhancement, and digital operations [1] - These measures have contributed to the overall improvement in profitability [1] Group 3: Asset Optimization - The company has actively integrated, adjusted, or divested certain business units that have long-term poor performance or weak strategic synergy, further optimizing asset allocation efficiency [1]

Core Viewpoint - The company is expected to turn a profit in 2025, reversing previous losses due to optimized business structure, effective cost control, and the clearing of inefficient assets [1][2]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [1]. - The company anticipates a turnaround from loss to profit, indicating a positive shift in financial performance [1]. Group 2: Reasons for Performance Change - Continuous optimization of the business structure has driven growth, particularly in high-margin refractive and optical businesses [2]. - Significant results from cost and expense management have been achieved through refined operational management, centralized procurement, and enhanced supply chain efficiency [2]. - The company has actively integrated, adjusted, or divested underperforming business units to improve asset allocation efficiency [2]. Group 3: Additional Information - The performance forecast is based on preliminary calculations by the company's finance department and has not yet been audited by an accounting firm [3]. - Final financial data will be disclosed in the company's 2025 annual report [3].

Group 1 - The core point of the article is that He Eye Hospital has announced an expected net profit for the year 2025, projecting earnings between 24 million to 36 million yuan, a significant turnaround from a loss of 27.3982 million yuan in the same period last year [2] Group 2 - The company is forecasting a positive financial performance for 2025, indicating a recovery and growth potential in its operations [2] - The previous year's loss highlights the challenges faced by the company, making the projected profit a notable improvement [2] - This announcement may influence investor sentiment positively, as it suggests a shift towards profitability [2]

Core Viewpoint - He Eye Hospital has announced a positive earnings forecast for 2025, projecting a significant turnaround from previous losses to a net profit range of 24 million to 36 million yuan [1] Financial Performance - The expected net profit attributable to shareholders for 2025 is between 24 million and 36 million yuan, compared to a loss of 27.3982 million yuan in the same period last year [1] - The forecasted net profit after deducting non-recurring gains and losses is estimated to be between 11 million and 16.5 million yuan, while the previous year's figure was a loss of 28.7877 million yuan [1]

Core Viewpoint - Liaoning He Eye Hospital Group Co., Ltd. has significantly improved its profitability due to business structure optimization, effective cost control, and the disposal of inefficient assets, with a projected net profit of 24 million to 36 million yuan for 2025, marking a turnaround to profitability [1] Group 1: Financial Performance - The company expects a net profit attributable to shareholders of 24 million to 36 million yuan for the fiscal year 2025 [1] - The projected net profit after deducting non-recurring gains and losses is estimated to be between 11 million and 16.5 million yuan, indicating a return to profitability [1] Group 2: Business Strategy - He Eye Hospital integrates medical education and research, focusing on a three-tier eye health service model aimed at comprehensive lifecycle eye health management [1] - The company is committed to the founder's vision of "Smart City of Light," emphasizing technological innovation to provide personalized and intelligent eye health management services [1] Group 3: Reasons for Performance Improvement - Continuous optimization of business structure with increased investment in high-margin refractive and optometry services has contributed to the improved performance [1] - Significant cost and expense control measures have been implemented, including refined operational management, centralized procurement optimization, supply chain efficiency improvements, and digital operations, leading to enhanced overall profitability [1] - The company has actively integrated, adjusted, or divested underperforming or strategically misaligned business units, further optimizing asset allocation efficiency [1]

何氏眼科表示，报告期内，公司业绩实现扭亏为盈，得益于业务结构优化、成本费用有效控制及低效资 产出清，公司盈利能力显著增强。 北京商报讯(记者丁宁)1月27日晚间，何氏眼科（301103）发布2025年业绩预告显示，公司预计2025年 实现归属净利润2400万元至3600万元，将实现扭亏为盈。 ...

报告期内，公司业绩实现扭亏为盈，得益于业务结构优化、成本费用有效控制及低效资产出清，公司盈 利能力显著增强，具体原因如下：1.持续优化业务结构，高毛利业务驱动增长：公司推进业务结构优 化，加大对高毛利的屈光业务与视光业务的投入和发展所致。2.成本与费用管控成效显著：公司全面推 行精细化运营管理，通过集中采购优化、供应链效率提升、数字化运营等赋能，实现降本增效，从而带 动了整体盈利能力的提升。3.推进低效资产出清：公司对部分长期效益不佳或战略协同性较弱的业务单 元实施了主动整合、调整或剥离，进一步优化了资产配置效率。 格隆汇1月27日丨何氏眼科(301103.SZ)公布，预计2025年归属于上市公司股东的净利润2,400万元–3,600 万元，同比扭亏为盈，扣除非经常性损益后的净利润1,100万元–1,650万元，同比扭亏为盈。 ...

每经AI快讯，何氏眼科（301103）1月27日发布业绩预告，预计2025年归母净利为2400万元~3600万 元，同比扭亏为盈，上年同期亏损2739.82万元。报告期内，公司业绩实现扭亏为盈，得益于业务结构 优化、成本费用有效控制及低效资产出清，公司盈利能力显著增强。 ...

人民财讯1月27日电，何氏眼科（301103）1月27日发布业绩预告，预计2025年归母净利2400万元—3600 万元，同比扭亏为盈，上年同期亏损2739.82万元。报告期内，公司业绩实现扭亏为盈，得益于业务结 构优化、成本费用有效控制及低效资产出清，公司盈利能力显著增强。 ...

何氏眼科公告，预计2025年度净利润为2400万元–3600万元，上年同期亏损2739.82万元。报告期内，公 司业绩实现扭亏为盈，得益于业务结构优化、成本费用有效控制及低效资产出清，公司盈利能力显著增 强。 ...